Mismatch Repair Proficient Colorectal Cancer

Oncology

Prevalence

135.0 / 100K

Incidence

36.0 / 100K/yr

4 drugs in development·2 companies·1 clinical trial

Drug Pipeline by Phase

Compare drugs

Cediranib vs OlaparibCediranib vs Neoadjuvant olaparib

Frequently asked questions

How many drugs are in development for Mismatch Repair Proficient Colorectal Cancer?

BioSniper tracks 4 drugs in development for Mismatch Repair Proficient Colorectal Cancer across 2 companies.

How many clinical trials target Mismatch Repair Proficient Colorectal Cancer?

There are 1 clinical trial targeting Mismatch Repair Proficient Colorectal Cancer tracked by BioSniper.

What is the prevalence of Mismatch Repair Proficient Colorectal Cancer?

The estimated prevalence of Mismatch Repair Proficient Colorectal Cancer is approximately 135.0 per 100,000 population.

Deep-dive into Mismatch Repair Proficient Colorectal Cancer

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Mismatch Repair Proficient Colorectal Cancer — Drugs in Development & Clinical Trials | BioSniper